Onderneming Merck Ltd NSE India S.E.
Aandelen
INE199A01012
Farmaceutische producten
Vakgebied
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
98,1
%
| 10 920 | 98,0 % | 12 059 | 98,1 % | +10,42% |
Shared Services
1,8
%
| 195 | 1,7 % | 224 | 1,8 % | +15,06% |
Scrap
0,1
%
| 6 | 0,1 % | 9 | 0,1 % | +37,10% |
Exports Incentives
0,0
%
| 23 | 0,2 % | 5 | 0,0 % | -76,96% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
89,2
%
| 10 075 | 90,4 % | 10 962 | 89,2 % | +8,81% |
International
10,8
%
| 1 070 | 9,6 % | 1 334 | 10,8 % | +24,70% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Milind Thatte
CEO | Chief Executive Officer | 55 | 01-04-18 |
Lokesh Chandak
DFI | Director of Finance/CFO | - | 01-04-23 |
Zeal Shah
CMP | Compliance Officer | - | 01-07-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 86 | 17-01-84 | |
Director/Board Member | 66 | 15-11-21 | |
Rani Ajit Jadhav
BRD | Director/Board Member | 76 | 05-02-15 |
Milind Thatte
CEO | Chief Executive Officer | 55 | 01-04-18 |
Aalok Agrawal
BRD | Director/Board Member | 49 | 01-06-19 |
Lokesh Chandak
DFI | Director of Finance/CFO | - | 01-04-23 |
Seema Sambasivan
BRD | Director/Board Member | - | 01-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 16 599 382 | 7 939 070 ( 47,83 %) | 0 | 47,83 % |
Bedrijfsgegevens
Procter & Gamble Health Ltd.
Godrej One, 8th Floor, Pirojshanagar Eastern Express Highway
400079, Mumbai
+91 22 6866 9000
http://www.pghealthindia.com![Adres Merck Ltd](https://cdn.zonebourse.com/static/address/9058973.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,78% | 43,29 mld. | |
+25,49% | 22,38 mld. | |
+19,25% | 15,51 mld. | |
+18,68% | 14,52 mld. | |
+54,64% | 12,93 mld. | |
-0,05% | 6,79 mld. | |
-11,41% | 6,56 mld. | |
+12,62% | 5,87 mld. | |
-8,87% | 5,73 mld. |